Merck (MRK) Long-Term Investments (2009 - 2026)

Merck (MRK) has 18 years of Long-Term Investments data on file, last reported at $1.1 billion in Q1 2026.

• Long-Term Investments for Q1 2026 came in at $1.1 billion, up 343.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 343.78% YoY), and the FY2025 annual result was $956.0 million, up 106.48% from the prior year.
• Long-Term Investments advanced to $1.1 billion in Q1 2026 per MRK's latest filing, from $956.0 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $1.3 billion in Q3 2023 and troughed at $238.0 million in Q2 2022.
• A 5-year average of $635.0 million and a median of $622.0 million in 2023 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2023 and 2026: Long-Term Investments plunged 75.17% in 2023, then jumped 343.78% in 2026.
• A 5-year view of Long-Term Investments shows it stood at $1.0 billion in 2022, then sank by 75.17% to $252.0 million in 2023, then jumped by 83.73% to $463.0 million in 2024, then soared by 106.48% to $956.0 million in 2025, then advanced by 15.59% to $1.1 billion in 2026.
• Business Quant data shows MRK's Long-Term Investments at $1.1 billion in Q1 2026, $956.0 million in Q4 2025, and $1.1 billion in Q3 2025.